Most Recent
Merck Sharp & Dohme attacks Wyeth’s ‘broad’ patent claims for Prevnar 13 vaccine
A showdown between global pharmaceutical giants over the world's best selling vaccine began Monday in Federal Court, with Merck Sharp & Dohme claiming three patents for Prevnar 13 sold by Pfizer's Wyeth are invalid and that its own vaccine offers greater protection against pneumococcal bacteria.
Landmark to pay $1M in ACCC case over barley claims
Grain supplier Seednet has agreed to pay $1 million to settle an enforcement action by the consumer watchdog alleging it misled farmers about the performance of its latest barley variety.
ASIC blasted for ‘vague’ case against Tennis Australia duo
A court has told the Australian Securities and Investments Commission to produce more detailed allegations against former Tennis Australia directors Harold Mitchell and Stephen Healy over Seven Network's five-year deal for the broadcast rights to the Australian Open after the regulator was slammed for a vague filing.
AMP admits another possible fees for no service scandal
Embattled wealth manager AMP has revealed its fees for no service scandal could cost the firm more than $1 billion in customer remediation, and that it might be facing another fees scandal.
Nestle unit wins patent for internet-connected coffee machine
A unit of Nestle unit has defeated an opposition to a patent for an internet-connected coffee machine that would allow users to read news and weather while making their morning coffee.
GSK defeats challenge to breakthrough RSV vaccine patent
GlaxoSmithKline has won approval for a patent for a vaccine to prevent a common respiratory virus affecting infants, beating out a challenge from a rival that has developed a competing vaccine.
Leyonhjelm keeps up parliamentary privilege fight in Sarah Hanson-Young case
Liberal Democrat senator David Leyonhjelm has made good on his threat to challenge a ruling that kept alive a defamation lawsuit brought by Greens senator Sarah Hanson-Young after he accused her of labelling all men rapists on the sidelines of a Senate debate.
Squire Patton Boggs refuses to hand over GetSwift group member details
Squire Patton Boggs has refused a request by rival Phi Finney McDonald for the details of group members it signed up to its now stayed shareholder class action against GetSwift, a court has learned, in the latest show of resistance by the losing law firm.
Fitch expert challenged in investor class action over toxic CDOs
An expert witness in an investor class action against Fitch Ratings over toxic financial products is no expert at all, the lead applicant told the court in contesting the admissibility of the expert's evidence.
ACCC dragging its feet with Captain Cook case, court hears
Vocational education provider Captain Cook College has panned the ACCC for delaying its recently filed case against the college by failing to prepare a statement of claim, despite already publicising the proceedings.